search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Perioperative antibiotic use in the treatment of acute inflammation of the gallbladder.


- candidate number10396
- NTR NumberNTR3089
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR29-sep-2011
- Secondary IDs VCMO Antonius Hospital Nieuwegein
- Public TitlePerioperative antibiotic use in the treatment of acute inflammation of the gallbladder.
- Scientific TitlePerioperative antibiotic use in the treatment of acute calculous cholecystitis.
- ACRONYMPEANUTS
- hypothesisExtended postoperative antibiotic prophylaxis will not reduce the infectious complication rate after laparoscopic cholecystectomy in acute cholecystitis.
- Healt Condition(s) or Problem(s) studiedAcute calculous cholecystitis
- Inclusion criteria1. Acute calculous cholecystitis;
2. APACHE-II score 1-6;
3. Written informed consent.
- Exclusion criteria1. < 18 years of age;
2. APACHE-II score ≥ 7;
3. Already receiving antibiotics prior to diagnosis;
4. Proven allergy to Cefuroxime/ Metronidazole;
5. Pregnancy.
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-jan-2012
- planned closingdate1-jan-2014
- Target number of participants158
- Interventions1. Extended postoperative antibiotic prophylaxis (cefuroxime 750 mgs 3dd & metronidazole 500mgs 3dd during 72 hours);
2. Postoperative clinical observation.
- Primary outcomeAll infectious complications.
- Secondary outcome1. Individual components of composite endpoint;
2. All other complications;
3. Total length of hospital stay;
4. Total direct and indirect costs.
- TimepointsInclusion of patients will take approximately two years. Total duration of follow up is one month.
An interim analysis will be performed every six months.
- Trial web sitewww.cholecystitis.nl
- statusplanned
- CONTACT FOR PUBLIC QUERIESMD. D. Boerma
- CONTACT for SCIENTIFIC QUERIESMD. D. Boerma
- Sponsor/Initiator Sint Antonius Ziekenhuis
- Funding
(Source(s) of Monetary or Material Support)
St Antonius Hospital, Nieuwegein
- PublicationsN/A
- Brief summaryIn the treatment of acute cholecystitis the use of antibiotics is disputable. It is current practice to administer a single prophylactic dose of intravenous antibiotics 15-30 minutes prior to the first incision. Whether postoperative prolongation of antibiotic treatment has any additional value in preventing infectious complications remains unclear but many surgeons still advise to do so. Since the agents are preferably administered through the intravenous route, hospital admission is lengthened and therefore costs are higher. In addition bacterial resistance can occur making future treatment more difficult.
Current literature and our own retrospective case series does not provide the surgical community with the much needed answer to the question whether prolonged postoperative antibiotic prophylaxis does decrease the infectious complication rate in low risk patients with acute cholecystitis.
Although selection bias is most certainly present in the available studies, results do not show any beneficial effect of prolonged antibiotic administration.
The PEANUTS trial is initiated to demonstrate that extended postoperative antibiotic therapy does not decrease the infectious complication rate in laparoscopic cholecystectomy for acute cholecystitis. It is designed as a multi centre randomized controlled trial, including low risk patients with acute calculous cholecystitis. Patients will be randomised to receive either extended postoperative antibiotic prophylaxis or clinical observation after laparoscopic cholecystectomy. The endpoint is a composed endpoint of all infectious complications.
- Main changes (audit trail)
- RECORD29-sep-2011 - 11-aug-2012


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl